COV2 nasal vaccine

nasal SARS-CoV-2 vaccine · Rokote Laboratories Finland Oy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for COV2 nasal vaccine, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus [Phase 1]